Company No:
Contents
30.11.2023 | 30.11.2022 | |||
£ | £ | |||
Fixed assets | ||||
Intangible assets |
|
|
||
186,733 | 0 | |||
Current assets | ||||
Debtors | 3 |
|
|
|
Cash at bank and in hand |
|
|
||
142,656 | 97,843 | |||
Creditors: amounts falling due within one year | 4 | (
|
(
|
|
Net current assets | 115,604 | 83,011 | ||
Total assets less current liabilities | 302,337 | 83,011 | ||
Net assets |
|
|
||
Capital and reserves | ||||
Called-up share capital | 5 |
|
|
|
Share premium account |
|
|
||
Capital redemption reserve |
|
|
||
Profit and loss account | (
|
(
|
||
Total shareholders' funds |
|
|
Directors' responsibilities:
The financial statements of Talamo Limited (registered number:
James Wace
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.
Talamo Dyslexia Diagnosis Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 3 Buckland House, William Prance Road, Plymouth, PL6 5WR, United Kingdom. The business address of the Company is 1010 Fladgate House, 4 Circus Road West, Battersea Power Station, London, SW11 8EX.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
The directors have assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.
Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.
Development costs | not amortised |
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
Year ended 30.11.2023 |
Period from 01.11.2021 to 30.11.2022 |
||
Number | Number | ||
Monthly average number of persons employed by the Company during the year, including directors |
|
|
30.11.2023 | 30.11.2022 | ||
£ | £ | ||
VAT recoverable |
|
|
|
Corporation tax |
|
|
|
Other debtors |
|
|
|
|
|
30.11.2023 | 30.11.2022 | ||
£ | £ | ||
Trade creditors |
|
|
|
Amounts owed to directors |
|
|
|
Accruals |
|
|
|
Other taxation and social security |
|
|
|
Other creditors |
|
|
|
|
|
30.11.2023 | 30.11.2022 | ||
£ | £ | ||
Allotted, called-up and fully-paid | |||
|
|
|
|
|
|
|
|
|
|
|
|
199.96 | 181.60 |
- On 9 January 2023 the company repurchased 855 ordinary B shares of £0.01p each at par.
- On 25 January 2023 1 ordinary A share of 0.01p was reclassified as a B ordinary share of £0.01p.
- On 24 February 2023 1,605 ordinary A shares of 0.01p each were issued at a price of £93.457943 per share.
- On 7 June 2023 the company issued 1,086 A ordinary shares of £0.01p each at a price of £101.28913 per share.
Transactions with the entity's directors
30.11.2023 | 30.11.2022 | ||
£ | £ | ||
Amounts owed to directors as at 30 November | 10,965 | 11,832 |